Merck inks research deal with Culmination Bio to leverage ‘powerful’ patient data platform

Merck inks research deal with Culmination Bio to leverage ‘powerful’ patient data platform

Source: 
Biopharma Reporter
snippet: 

Merck has signed a R&D collaboration deal with data and technology company Culmination Bio, a spinoff from Intermountain Health.